Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:57:49 GMT 2023
by
admin
on
Sat Dec 16 14:57:49 GMT 2023
|
| Protein Type | RECEPTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
810S9KV11R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q01726
Created by
admin on Sat Dec 16 14:57:50 GMT 2023 , Edited by admin on Sat Dec 16 14:57:50 GMT 2023
|
PRIMARY | |||
|
810S9KV11R
Created by
admin on Sat Dec 16 14:57:50 GMT 2023 , Edited by admin on Sat Dec 16 14:57:50 GMT 2023
|
PRIMARY |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_29 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
AGONIST -> TARGET | |||
|
RADIOLIGAND->TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
Melanotan II produces melanogenesis by activation of the MC1 receptor.
Ki
|
||
|
WEAK INHIBITOR->TARGET |
BINDING
|
||
|
AGONIST -> TARGET |
Biased agonist: AP1189 reduced cytokine release but no melanogenesis was induced.
|
||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Binding assay
Kd
|
||
|
AGONIST -> TARGET |
Binding Assay
IC50
|
||
|
|
AGONIST -> TARGET |
Ki
|
||
|
AGONIST -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|